Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeremy S Abramson
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
635 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Community Cancer Institute
Clovis, California, United States
- University Oncology Associates
Clovis, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Cancer Center of Colorado at Sloan'S Lake
Denver, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- National Jewish Health-Main Campus
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Oct 2019
- Primary completion
- 1 Apr 2028
- Completion
- 1 Apr 2028
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 363
- Registry id
- NCT03984448
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.